JAMES HORNYAK: Open Payments
NPI 1609264100 · INVERNESS, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,645 in 48 payments from 4 companies in 2025. Trend: 2023 $763 · 2024 $1,360 · 2025 $1,645
Food & beverage: $1,645
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 19 | $634 |
| Teva Pharmaceuticals USA, Inc. | 16 | $433 |
| ACADIA Pharmaceuticals Inc | 11 | $414 |
| Alpha Cognition USA, Inc. | 2 | $165 |
Products named: INGREZZA, AUSTEDO XR, NUPLAZID, Zunveyl.
Industry payments across FL — which companies pay providers there.
